The Anti-Tumor Activity of IGM-8444, an Agonistic Death Receptor 5 (DR5) IgM Antibody, is Sensitized in Combination with Chemotherapy and Bcl-2 Inhibitors in NHL and AML

62nd American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2020
Session: 625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents
Abstract Number: 2093, December 6, 2020

Beatrice Wang et al.,
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

ASH 2020 IGM-8444 Poster Abstract #2093

Posted in publications.